DSC2 and breast cancer: Desmoglein 2, desmocollin 2 (DSC2) and plakophilin 1 (PKP1) have been recently linked to an increased metastatic potential of breast cancer cells by promoting cell clustering and enhanced survival during the tumour cell dissemination process [25, 31].